Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF-β and NF-κB
-
- LEE Wen-Chin
- Division of Nephrology, Department of Internal Medicine, Show Chwan Memorial Hospital Department of Life Sciences, National Chung Hsing University Central Taiwan University of Science and Technology
-
- CHEN Hong-Chen
- Department of Life Sciences, National Chung Hsing University
-
- WANG Chih-Ying
- Institute of Biochemistry and Biotechnology, Medical College, Chung Shan Medical University
-
- LIN Pei-Ying
- Institute of Biochemistry and Biotechnology, Medical College, Chung Shan Medical University
-
- OU Tin-Tsz
- Institute of Biochemistry and Biotechnology, Medical College, Chung Shan Medical University
-
- CHEN Chen-Chang
- Department of Pathology, Taichung Veterans General Hospital
-
- WEN Mei-Chin
- Department of Pathology, Taichung Veterans General Hospital
-
- WANG John
- Department of Pathology, Taichung Veterans General Hospital
-
- LEE Huei-Jane
- Institute of Biochemistry and Biotechnology, Medical College, Chung Shan Medical University Department of Biochemistry, School of Medicine, Chung Shan Medical University Clinical Laboratory, Chung Shan Medical University Hospital
書誌事項
- タイトル別名
-
- Cilostazol Ameliorates Nephropathy in Type 1 Diabetic Rats Involving Improvement in Oxidative Stress and Regulation of TGF-.BETA. and NF-.KAPPA.B
- Cilostazol ameliorates nephropathy in type 1 diabetic rats involving improvement in oxidative stress and regulation of TGF v and NF k B
この論文をさがす
抄録
Diabetic nephropathy is characterized as the progressive development of renal insufficiency in a setting of hyperglycemia. Previous studies indicate that reactive oxygen species (ROS) play an important role in high glucose-induced renal injury. Cilostazol was reported to lower the production of superoxide significantly in situ. We hypothesized that cilostazol administration in streptozotocin-induced diabetic rats exerts effects via improving oxidative stress. Male Sprague–Dawley rats were fed with cilostazol (5 mg/kg or 25 mg/kg) for 12 weeks after streptozotocin-induced diabetes mellitus. The results showed that cilostazol decreased reactive oxygen species activity significantly in the kidneys of diabetic rats and improved the urine albumin/creatinine ratio. Cilostazol can also improve the levels of serum cholesterol, triglyceride, and LDL-cholesterol. Additionally, diabetes-caused increased glomerular size, TGF-β, and NF-κB decreased under treatment with cilostazol in diabetic rats. Our results indicate that cilostazol has beneficial effects in early diabetic nephropathy.
収録刊行物
-
- Bioscience, Biotechnology, and Biochemistry
-
Bioscience, Biotechnology, and Biochemistry 74 (7), 1355-1361, 2010
公益社団法人 日本農芸化学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681456105216
-
- NII論文ID
- 10027556949
-
- NII書誌ID
- AA10824164
-
- COI
- 1:STN:280:DC%2BC3cjgvFahtw%3D%3D
-
- ISSN
- 13476947
- 09168451
-
- NDL書誌ID
- 10766401
-
- PubMed
- 20622454
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可